QuickView for CPAMD3 (gene)

1. Targeting therapeutic agent against C3b/C4b, SB002, on the inflammation-induced bone loss in experim…
2. Multifaceted Activities of Seven Nanobodies against Complement C4b.
3. Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases.
4. Impact of Homozygous C4A Deficiency on Clinical Presentation of Systemic Lupus Erythematosus.
5. Complement C4A Regulates Autoreactive B Cells in Murine Lupus.

There were no clinical trials for CPAMD3